The company said it is on track to complete a clinical validation by the end of next year, after which it would launch its assay for clinical use.
The firm is developing a biomarker panel to detect mutations in mesenchymal cells, with the goal of guiding drug treatment and improving earlier patient intervention.
Australian researchers are studying the prevalence of genetic alterations among men with metastatic prostate cancer, the Financial Review reports.
In an opinion piece in the Irish Times, Anne Jones, the chief executive of Genomics Medicine Ireland, argues that Ireland needs private investment in genomic medicine.
The company sold nearly twice as many tests as in Q2 last year, with clinical test revenue more than doubling and total revenue reaching $54 million for the quarter.
The company has signed a new, multiyear agreement with the Korean health system to build a data sharing network to support precision cancer care in East Asia.
Biocartis' Idylla called some colorectal cancer samples negative that Sysmex Inostics's OncoBEAM called positive, but the clinical implications may be complex.
New publications have provided more detailed examples of the platform's research utility and hinted at future clinical applications in immuno-oncology.
Startup healthcare analytics company Progknowse will work with hospitals and sequencing labs to build a clinical and genomic dataset.
NEC said the deal will bolster its cancer immunotherapy development programs, which are focused on ovarian cancer and head and neck cancer.
The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.
The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.
New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.
In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.